Kazuhiro Toyoda Selected Research

Fibrosis (Cirrhosis)

1/2020	Association between steatohepatitis biomarkers and hepatocellular carcinoma after hepatitis C elimination.
1/2017	Comparison of the Abbott RealTime HCV and Roche COBAS Ampliprep/COBAS TaqMan HCV assays for the monitoring of sofosbuvir-based therapy.
2/2016	Impact of HCV kinetics on treatment outcome differs by the type of real-time HCV assay in NS3/4A protease inhibitor-based triple therapy.
1/2015	Non-invasive fibrosis assessment predicts sustained virological response to telaprevir with pegylated interferon and ribavirin for chronic hepatitis C.
1/2006	Long-term lamivudine treatment for chronic hepatitis B in Japanese patients: a project of Kyushu University Liver Disease Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuhiro Toyoda Research Topics

Disease

18	Infections 01/2022 - 12/2007
12	Chronic Hepatitis C 01/2018 - 07/2005
6	HIV Infections (HIV Infection) 01/2017 - 11/2012
5	Fibrosis (Cirrhosis) 01/2020 - 01/2006
5	Chronic Hepatitis B 02/2015 - 01/2006
3	Hepatitis C 12/2021 - 09/2014
3	Coinfection 01/2018 - 11/2012
3	Immune Reconstitution Inflammatory Syndrome 01/2017 - 11/2012
3	Liver Diseases (Liver Disease) 05/2014 - 01/2006
3	Viremia 12/2011 - 07/2005
2	Respiratory Insufficiency (Respiratory Failure) 08/2022 - 01/2011
2	Inflammation (Inflammations) 01/2019 - 01/2017
2	Hepatitis B 01/2018 - 04/2015
2	Virus Diseases (Viral Diseases) 01/2017 - 12/2007
2	Insulin Resistance 09/2012 - 12/2007
2	Neoplasms (Cancer) 04/2009 - 02/2009
2	Atopic Dermatitis (Atopic Eczema) 09/2008 - 09/2007
1	COVID-19 08/2022
1	Pulmonary Embolism 08/2022
1	Thrombosis (Thrombus) 08/2022
1	Thrombocytopenia (Thrombopenia) 08/2022
1	Atherosclerosis 12/2021
1	Glucose Intolerance 12/2021
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Fatty Liver 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Protein-Energy Malnutrition (Marasmus) 01/2019
1	Communicable Diseases (Infectious Diseases) 01/2019
1	Malnutrition (Nutritional Deficiencies) 01/2019
1	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 01/2018
1	Arteriosclerosis 01/2018
1	Exanthema (Rash) 01/2018
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2018
1	Iron Deficiencies 01/2018
1	Bacterial Infections (Bacterial Infection) 01/2017
1	Prediabetic State (Prediabetes) 06/2016
1	Disease Resistance 03/2016
1	Persistent Infection 03/2016
1	Carotid Artery Diseases 02/2015
1	Chronic Renal Insufficiency 02/2015
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2015
1	Anemia 09/2014
1	Hemophilia A (Haemophilia) 05/2014

Drug/Important Bio-Agent (IBA)

10	InterferonsIBA 01/2015 - 07/2005
9	Ribavirin (Virazole)FDA LinkGeneric 01/2015 - 07/2005
8	Antiviral Agents (Antivirals)IBA 01/2018 - 04/2010
7	RNA (Ribonucleic Acid)IBA 01/2017 - 07/2005
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2007
5	telaprevirIBA 01/2015 - 08/2013
4	AlbuminsIBA 12/2021 - 06/2016
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2020 - 11/2012
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2006
3	Hepatitis B e AntigensIBA 04/2015 - 01/2006
2	Plant Growth Regulators (Plant Hormones)IBA 01/2022 - 03/2016
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2020
2	InterleukinsIBA 12/2021 - 09/2012
2	adefovirIBA 02/2015 - 06/2011
2	Pharmaceutical PreparationsIBA 09/2014 - 02/2014
2	NucleosidesIBA 11/2012 - 12/2011
2	Lamivudine (Epivir)FDA Link 06/2011 - 01/2006
1	remdesivirIBA 08/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 08/2022
1	apixabanIBA 08/2022
1	Heparin (Liquaemin)FDA LinkGeneric 08/2022
1	AnticoagulantsIBA 08/2022
1	fibrin fragment D (D-dimer)IBA 08/2022
1	Type III Secretion SystemsIBA 01/2022
1	HDL CholesterolIBA 12/2021
1	LDL CholesterolIBA 12/2021
1	Inositol (Myoinositol)IBA 12/2021
1	Amino Acids FDA Link 12/2021
1	Phospholipases (Phospholipase)IBA 01/2020
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2020
1	Minocycline (Cyclops)FDA LinkGeneric 01/2018
1	Amoxicillin (Wymox)FDA LinkGeneric 01/2018
1	SofosbuvirIBA 01/2018
1	Fibroblast Growth Factor-23IBA 01/2018
1	MagnesiumIBA 01/2018
1	IronIBA 01/2018
1	C-Reactive ProteinIBA 01/2017
1	IgG Receptors (Fc gamma RI)IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 06/2016
1	EndostatinsIBA 06/2016
1	Hormones (Hormone)IBA 03/2016
1	Acyl-ButyrolactonesIBA 05/2015
1	AntigensIBA 04/2015
1	adefovir dipivoxil (Hepsera)FDA Link 02/2015
1	Triglycerides (Triacylglycerol)IBA 02/2015
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2015
1	HCV NS3-4A Protease InhibitorsIBA 09/2014
1	vaniprevirIBA 09/2014
1	Tenofovir (Viread)FDA Link 05/2014
1	Emtricitabine (Emtriva)FDA Link 05/2014
1	Protease Inhibitors (Protease Inhibitor)IBA 05/2014
1	Blood Coagulation Factors (Coagulation Factor)IBA 05/2014
1	Raltegravir Potassium FDA Link 05/2014

Therapy/Procedure

10	Therapeutics 08/2022 - 05/2011
5	Art Therapy 01/2017 - 11/2012
3	Aftercare (After-Treatment) 08/2022 - 11/2003
2	Renal Dialysis (Hemodialysis) 01/2019 - 01/2018